IDYA
NASDAQ
$35.99
Ideaya Biosciences Inc (IDYA)
IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality, is focused on the discovery and development of targeted therapies for selected patient populations using molecular diagnostics. The company is headquartered in South San Francisco, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $52.29 (+45.29%)
Market Cap
$3.23B
Revenue 5Y CAGR
+53.10%
Free Cash Flow Yield
-2.72%
Beta (5Y)
1.11
Price Chart
Valuation
Market Cap$3.23B
Forward P/E4.65
P/S15.70
P/B3.76
Profitability
Total Revenue (TTM)$225M
Gross Profit (TTM)-$114M
EBITDA-$181M
Profit Margin-62.2%
Operating Margin-1655%
EPS-$1.59
Financial Health
Free Cash Flow Yield-2.72%
Growth & Risk
EPS 5Y CAGR+8.12%
Revenue 5Y CAGR+53.10%
Beta (5Y)1.11
Sharpe Ratio1.21